UniProt ID | G45IP_HUMAN | |
---|---|---|
UniProt AC | Q8TAE8 | |
Protein Name | Growth arrest and DNA damage-inducible proteins-interacting protein 1 | |
Gene Name | GADD45GIP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 222 | |
Subcellular Localization | Mitochondrion . Nucleus . Using N-terminally tagged constructs, has been found in the nucleus (PubMed:12482659). C-terminally tagged constructs are targeted exclusively to mitochondria (PubMed:22453275). This discrepancy may be explained by masking o | |
Protein Description | Acts as a negative regulator of G1 to S cell cycle phase progression by inhibiting cyclin-dependent kinases. Inhibitory effects are additive with GADD45 proteins but occurs also in the absence of GADD45 proteins. Acts as a repressor of the orphan nuclear receptor NR4A1 by inhibiting AB domain-mediated transcriptional activity. May be involved in the hormone-mediated regulation of NR4A1 transcriptional activity. May play a role in mitochondrial protein synthesis.. | |
Protein Sequence | MAASVRQARSLLGVAATLAPGSRGYRARPPPRRRPGPRWPDPEDLLTPRWQLGPRYAAKQFARYGAASGVVPGSLWPSPEQLRELEAEEREWYPSLATMQESLRVKQLAEEQKRREREQHIAECMAKMPQMIVNWQQQQRENWEKAQADKERRARLQAEAQELLGYQVDPRSARFQELLQDLEKKERKRLKEEKQKRKKEARAAALAAAVAQDPAASGAPSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | ASVRQARSLLGVAAT HHHHHHHHHHHHHHH | 30.84 | 24719451 | |
25 | Phosphorylation | LAPGSRGYRARPPPR CCCCCCCCCCCCCCC | 10.45 | 24719451 | |
47 | Phosphorylation | PDPEDLLTPRWQLGP CCHHHHCCCCCCCCH | 20.36 | - | |
55 | Methylation | PRWQLGPRYAAKQFA CCCCCCHHHHHHHHH | 31.74 | - | |
59 | Ubiquitination | LGPRYAAKQFARYGA CCHHHHHHHHHHHCC | 37.46 | 22817900 | |
59 | Acetylation | LGPRYAAKQFARYGA CCHHHHHHHHHHHCC | 37.46 | 27452117 | |
64 | Phosphorylation | AAKQFARYGAASGVV HHHHHHHHCCCCCCC | 14.00 | - | |
74 | Phosphorylation | ASGVVPGSLWPSPEQ CCCCCCCCCCCCHHH | 22.61 | - | |
78 | Phosphorylation | VPGSLWPSPEQLREL CCCCCCCCHHHHHHH | 29.50 | - | |
93 | Phosphorylation | EAEEREWYPSLATMQ HHHHHCHHHHHHHHH | 4.34 | 20068231 | |
95 | Phosphorylation | EEREWYPSLATMQES HHHCHHHHHHHHHHH | 18.23 | - | |
98 | Phosphorylation | EWYPSLATMQESLRV CHHHHHHHHHHHHHH | 25.36 | - | |
102 | Phosphorylation | SLATMQESLRVKQLA HHHHHHHHHHHHHHH | 12.46 | 20068231 | |
113 | Ubiquitination | KQLAEEQKRREREQH HHHHHHHHHHHHHHH | 57.62 | 24816145 | |
127 | Ubiquitination | HIAECMAKMPQMIVN HHHHHHHHCHHHHHH | 24.99 | 21890473 | |
166 | Phosphorylation | EAQELLGYQVDPRSA HHHHHHCCCCCHHHH | 12.82 | 24927040 | |
184 | Ubiquitination | ELLQDLEKKERKRLK HHHHHHHHHHHHHHH | 68.20 | 22817900 | |
185 | Ubiquitination | LLQDLEKKERKRLKE HHHHHHHHHHHHHHH | 54.07 | 22817900 | |
188 | Ubiquitination | DLEKKERKRLKEEKQ HHHHHHHHHHHHHHH | 64.27 | 22817900 | |
221 | Phosphorylation | PAASGAPSS------ HHHCCCCCC------ | 48.42 | 17069992 | |
222 | Phosphorylation | AASGAPSS------- HHCCCCCC------- | 43.09 | 25262027 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
221 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of G45IP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of G45IP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NR4A1_MOUSE | Nr4a1 | physical | 15459248 | |
GA45A_HUMAN | GADD45A | physical | 12716909 | |
GA45G_HUMAN | GADD45G | physical | 12716909 | |
GA45B_HUMAN | GADD45B | physical | 12716909 | |
NF2L2_HUMAN | NFE2L2 | physical | 20427290 | |
A4_HUMAN | APP | physical | 21832049 | |
RM12_HUMAN | MRPL12 | physical | 22939629 | |
TSR1_HUMAN | TSR1 | physical | 22939629 | |
TM177_HUMAN | TMEM177 | physical | 22939629 | |
RM11_HUMAN | MRPL11 | physical | 22939629 | |
RM14_HUMAN | MRPL14 | physical | 22939629 | |
TAP1_HUMAN | TAP1 | physical | 22939629 | |
PTH2_HUMAN | PTRH2 | physical | 22939629 | |
ELF3_HUMAN | ELF3 | physical | 19801644 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY. |